Tema Oncology ETF (CANC)
37.28
+0.31
(+0.84%)
USD |
NASDAQ |
Jan 22, 16:00
37.28
0.00 (0.00%)
After-Hours: 20:00
Price Chart
Key Stats
| Net Expense Ratio | Discount or Premium to NAV | Total Assets Under Management | 30-Day Average Daily Volume |
|---|---|---|---|
| 0.75% | 0.35% | 143.31M | 47891.67 |
| Weighted Average Dividend Yield | Turnover Ratio (Generic) | 1 Year Fund Level Flows | Max Drawdown (Since Inception) |
| 0.83% | 95.00% | 39.87M | Upgrade |
Basic Info
| Investment Strategy | |
| The Fund seeks to provide long-term growth. Under normal circumstances, the Tema Oncology ETF seeks to achieve its investment objective by investing at least 80% of its net assets, which include borrowings for investment purposes, in publicly listed companies that derive at least 50% of revenues from oncology. |
| General | |
| Security Type | Exchange-Traded Fund |
| Equity Style | Multi Cap Growth |
| Broad Asset Class | Sector Equity |
| Broad Category | Equity |
| Global Peer Group | Equity Sector Healthcare |
| Peer Group | Global Health/Biotechnology Funds |
| Global Macro | Equity Industry Sector |
| US Macro | World Sector Equity Funds |
| YCharts Categorization | -- |
| YCharts Benchmark | -- |
| Prospectus Objective | Global Health/Biotechnology Funds |
| Fund Owner Firm Name | Tema |
| Broad Asset Class Benchmark Index | |
| ^MSWNTR | 100.0% |
Performance Versus Peer Group
Annual Total Returns Versus Peers
As of January 22, 2026.
Asset Allocation
As of December 31, 2025.
| Type | % Net |
|---|---|
| Cash | 0.66% |
| Stock | 98.75% |
| Bond | 0.58% |
| Convertible | 0.00% |
| Preferred | 0.00% |
| Other | 0.00% |
Basic Info
| Investment Strategy | |
| The Fund seeks to provide long-term growth. Under normal circumstances, the Tema Oncology ETF seeks to achieve its investment objective by investing at least 80% of its net assets, which include borrowings for investment purposes, in publicly listed companies that derive at least 50% of revenues from oncology. |
| General | |
| Security Type | Exchange-Traded Fund |
| Equity Style | Multi Cap Growth |
| Broad Asset Class | Sector Equity |
| Broad Category | Equity |
| Global Peer Group | Equity Sector Healthcare |
| Peer Group | Global Health/Biotechnology Funds |
| Global Macro | Equity Industry Sector |
| US Macro | World Sector Equity Funds |
| YCharts Categorization | -- |
| YCharts Benchmark | -- |
| Prospectus Objective | Global Health/Biotechnology Funds |
| Fund Owner Firm Name | Tema |
| Broad Asset Class Benchmark Index | |
| ^MSWNTR | 100.0% |